CLEC4C

CLEC4C 분자 정보

영어 이름C-Type lectin domain family 4 member C시판 약물 수0
임상 약물 수9표적 별명DLEC,HECL,C-type lectin superfamily member 7,CLEC4C,BDCA2,UNQ9361/PRO34150,C-type lectin domain family 4 member C,Dendritic lectin,C-Type (Calcium Dependent, Carbohydrate-Recognition Domain) Lectin, Superfamily Member 7,C-Type Lectin Domain Family 4, Member C,CLECSF11,CLECSF7,BDCA-2,C-Type (Calcium Dependent, Carbohydrate-Recognition Domain) Lectin, Superfamily Member 11,Blood Dendritic Cell Antigen 2 Protein,Blood Dendritic Cell Antigen 2,Dendritic Cell Lectin B,CD303 Antigen,PRO34150,CD303
최고 연구 개발 단계Phase 3 Clinical
영어 이름C-Type lectin domain family 4 member C
표적 별명DLEC,HECL,C-type lectin superfamily member 7,CLEC4C,BDCA2,UNQ9361/PRO34150,C-type lectin domain family 4 member C,Dendritic lectin,C-Type (Calcium Dependent, Carbohydrate-Recognition Domain) Lectin, Superfamily Member 7,C-Type Lectin Domain Family 4, Member C,CLECSF11,CLECSF7,BDCA-2,C-Type (Calcium Dependent, Carbohydrate-Recognition Domain) Lectin, Superfamily Member 11,Blood Dendritic Cell Antigen 2 Protein,Blood Dendritic Cell Antigen 2,Dendritic Cell Lectin B,CD303 Antigen,PRO34150,CD303
시판 약물 수0
임상 약물 수9
최고 연구 개발 단계Phase 3 Clinical

CLEC4C 제품 목록

  • 속성

    Protein (6)

  • 제품 라이브러리

    온라인 (6)

  • Human (3)Cynomolgus (3)

  • 태그

    Fc Tag (2)His Tag (2)His Tag & Avi Tag (2)

  • 마커

    Unconjugated (4)Biotin-labeled (2)

CLEC4C분자 배경

CLEC4C (C-type lectin domain family 4 member C), also known as BDCA2, CLECSF11, CLECSF7, DLEC and CD303. Lectin-type cell surface receptor which may play a role in antigen capturing by dendritic cell. Specifically recognizes non-sialylated galactose-terminated biantennary glycans containing the trisaccharide epitope Gal(beta1-3/4)GlcNAc(beta1-2)Man. Binds to serum IgG. Efficiently targets ligand into antigen-processing and peptide-loading compartments for presentation to T-cells. May mediate potent inhibition of induction of IFN-alpha/beta expression in plasmacytoid dendritic cells. May act as a signaling receptor that activates protein-tyrosine kinases and mobilizes intracellular calcium.

CLEC4C분자 별명

DLEC,CLEC4C,BDCA-2,CD303,CLECSF11,CLECSF7, HECL

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
LitifilimabBIIB-059Phase 3 ClinicalBiogen IncLupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
SSGJ-626SSGJ-626; 626Phase 2 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdLupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
DB-2304DB-2304Phase 2 ClinicalDuality Biologics (Suzhou) Co LtdAutoimmune Diseases; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
ANB-101CBS-004; ANB101Phase 1 ClinicalCapella Bioscience LtdInflammation; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Scleroderma, Systemic
상세
BCD-256BCD-256Phase 1 ClinicalBIOCAD JSCLupus Erythematosus, Systemic
상세
GB-19GB-19; GB19Phase 1 ClinicalShandong Kexing Bio-Products Co LtdLupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
Recombinant anti-BDCA2 humanized monoclonal antibody (Sansheng Guojian)Phase 1 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdLupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
HC-022HC-022; HC022Phase 1 ClinicalShanghai Hongcheng Pharmaceutical Co LtdLupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
상세
LBL-047DNTH-212; LBL-047; DNTH212Phase 1 ClinicalNanjing Leadsbiolabs Co LtdAutoimmune Diseases; Lupus Erythematosus, Systemic
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호